Atlas One · Host Biology · Scale 03 — Molecular

CTLA-4

CD152; inhibitory receptor on T cells competing with CD28 for B7-1/B7-2 co-stimulation — suppresses T cell priming in lymph nodes. Blocked by ipilimumab (anti-CTLA-4 IgG1); combined with anti-PD-1 (nivolumab) as standard of care in advanced melanoma and RCC.

Also known as: CD152, cytotoxic T-lymphocyte-associated protein 4, CTLA4, CD152 checkpoint

Scale 03 — MolecularScale
draftStatus
2026-06-06Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
ctla-4

CTLA-4

CD152; inhibitory receptor on T cells competing with CD28 for B7-1/B7-2 co-stimulation — suppresses T cell priming in lymph nodes. Blocked by ipilimumab (anti-CTLA-4 IgG1); combined with anti-PD-1 (nivolumab) as standard of care in advanced melanoma and RCC.